ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2212

Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA

Dalit Ashany1, Susan Goodman 2, Haley Tornberg 1, Donald McMahon 3, Douglas Mintz 4, Linda Russell 5 and Emily Stein 1, 1Hospital for Special Surgery, New York, NY, 2Hospital For Special Surgery/Weill Cornell Medicine, New York, NY, 3Donald J.McMahon Statistical Consulting, South Nyack, NY, 4Hospital for Special Surgery, Division of Radiology and Imaging, New York, 5Hospital for Special Surgery, New York

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: axial spondyloarthritis, Bone density, HR-pQCT and DXA, Musculoskeletal

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Axial Spondyloarthritis (axSpA) is characterized by abnormal bone formation that produces syndesmophytes, while paradoxically, inflammation causes increased bone resorption and skeletal fragility. Detection of osteoporosis using DXA can be challenging as syndesmophytes falsely elevate spine areal bone mineral density (aBMD). In contrast, high-resolution peripheral QCT (HRpQCT) measures volumetric BMD (vBMD) and microarchitecture and is not subject to this artifact. This study investigated skeletal health in a cohort with axSpA using aBMD, trabecular bone score (TBS), a method for estimation of spine trabecular bone quality, and HRpQCT. We hypothesized that TBS and HRpQCT would reveal skeletal abnormalities in axSpA, while aBMD by DXA would appear normal.

Methods: Patients fulfilling the imaging arm of the ASAS criteria who were enrolled as part of an ongoing longitudinal study had DXA measurements of aBMD of spine, hip and1/3 radius, and TBS. Trabecular (Tb) and cortical (Ct) vBMD and microarchitecture were measured by HRpQCT (Xtreme CT2, voxel size ~61 µm) at the distal radius and tibia. DXA in axSpA were compared with normative populations of age and sex matched individuals (Z-Scores). HRpQCT values were compared to a healthy reference population of young sex-matched adults. T-tests compared skeletal parameters in subjects and normative populations. Spearman correlations related skeletal parameters to disease features.

Results: 18 subjects were enrolled; 56% male, age 42+13 yrs. On average, subjects had symptoms for 14 yrs and had received a diagnosis of axSpA 6 yrs prior to study enrollment. BASDAI and other criteria reflected high disease activity (Table 1). The majority of subjects had normal aBMD by DXA. TBS was normal in the majority (67%). By HRpQCT at the radius, axSpA had lower Tb vBMD (-0.9 SD) and Tb thickness (-1.7 SD) than the reference population. At the tibia, axSpA had lower total (-0.9 SD), Ct (-1.5 SD) and Tb vBMD (-1.2 SD) and Tb thickness (-1.4 SD; p< 0.01 for all). Longer duration of symptoms was related to worse vBMD and microarchitecture, tibia: total vBMD (r=-0.83; p< 0.0001), Tb density (r=-0.76; p< 0.0005), Tb number (r=-0.51; p< 0.04) and Tb separation (r=0.61; p< 0.01) and radius: Tb density (r=-0.64; o< 0.1), Tb number (-0.50; p< 0.04) and Tb separation (r= 0.57; p< 0.02). Current disease activity did not relate to HRpQCT abnormalities.

Conclusion: Subjects with active axSpA had low vBMD and microarchitectural abnormalities by HRpQCT despite normal DXA and TBS. Abnormalities were most pronounced at the tibia and related to duration of symptoms. Larger studies are needed to confirm our findings, which suggest that long-term impairment in mobility may contribute to skeletal abnormalities in patients with axSpA.


Table 1 Novarts


Disclosure: D. Ashany, None; S. Goodman, BMC Rheumatology, 5, 6, Calgene, 5, Celgene, 5, Current Rheumatology reports, 5, Current Rheumatology Reports, 6, Horizon, 2, 5, horizon, 2, Novartis, 2, 5, NYU College of Medicine, 3, NYU Langone College of Medicine, 3, Pfizer, 2, 5, Regenosine, 4, 9, Roche, 2, UCB, 5; H. Tornberg, None; D. McMahon, None; D. Mintz, Current Rheumatology Reviews Journal, 6, American Registry of Radiologic Technologists Registry Exam, 5; L. Russell, Arthritis Foundation, 6; E. Stein, Novartis, 2.

To cite this abstract in AMA style:

Ashany D, Goodman S, Tornberg H, McMahon D, Mintz D, Russell L, Stein E. Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/patients-with-axial-spondyloarthritis-have-abnormal-microarchitecture-despite-normal-areal-bone-mineral-density-and-trabecular-bone-score-by-dxa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-axial-spondyloarthritis-have-abnormal-microarchitecture-despite-normal-areal-bone-mineral-density-and-trabecular-bone-score-by-dxa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology